Jordan Jones

1.3k total citations
31 papers, 923 citations indexed

About

Jordan Jones is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Jordan Jones has authored 31 papers receiving a total of 923 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Jordan Jones's work include Glioma Diagnosis and Treatment (7 papers), Single-cell and spatial transcriptomics (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Jordan Jones is often cited by papers focused on Glioma Diagnosis and Treatment (7 papers), Single-cell and spatial transcriptomics (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). Jordan Jones collaborates with scholars based in Australia, United States and United Kingdom. Jordan Jones's co-authors include R. V. Jeffreys, Sharon S. Krag, Michael J. Betenbaugh, Pierre Morell, Kotaro Suzuki, Glenn K. Matsushima, Jeffrey L. Mason, Masako Taniike, Bernat Soria and Mark Burcin and has published in prestigious journals such as The Lancet, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Jordan Jones

28 papers receiving 896 citations

Peers

Jordan Jones
Sameh Geha Canada
Hsin-I Ma Taiwan
Soverin Karmiol United States
Aparna Kaul United States
Bing Liao China
Jordan Jones
Citations per year, relative to Jordan Jones Jordan Jones (= 1×) peers Huiming Xu

Countries citing papers authored by Jordan Jones

Since Specialization
Citations

This map shows the geographic impact of Jordan Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordan Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordan Jones more than expected).

Fields of papers citing papers by Jordan Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordan Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordan Jones. The network helps show where Jordan Jones may publish in the future.

Co-authorship network of co-authors of Jordan Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Jordan Jones. A scholar is included among the top collaborators of Jordan Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordan Jones. Jordan Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jones, Jordan, Britta Engelhardt, Jonathan Flax, et al.. (2025). Shear Conditioning Promotes Microvascular Endothelial Barrier Resilience in a Human BBB‐on‐a‐Chip Model of Systemic Inflammation Leading to Astrogliosis. Advanced Science. 12(43). e08271–e08271. 1 indexed citations
2.
Jones, Jordan, Hong Nguyen, Stephen Q. Wong, et al.. (2024). Plasma ctDNA liquid biopsy of IDH1, TERTp, and EGFRvIII mutations in glioma. Neuro-Oncology Advances. 6(1). 8 indexed citations
3.
Jones, Jordan, Kate Jones, Stephen Q. Wong, et al.. (2024). Plasma ctDNA enables early detection of temozolomide resistance mutations in glioma. Neuro-Oncology Advances. 6(1). vdae041–vdae041. 8 indexed citations
4.
Whittle, James R., Mark Rosenthal, M A Spiteri, et al.. (2024). 443O A perioperative study of safusidenib in patients with IDH1 mutated glioma. Annals of Oncology. 35. S407–S407.
5.
Bezawork‐Geleta, Ayenachew, Jordan Jones, Hong Nguyen, et al.. (2023). The Interleukin-11/IL-11 Receptor Promotes Glioblastoma Survival and Invasion under Glucose-Starved Conditions through Enhanced Glutaminolysis. International Journal of Molecular Sciences. 24(4). 3356–3356. 5 indexed citations
6.
Jones, Jordan, et al.. (2021). Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Journal of Neuro-Oncology. 154(3). 265–274. 4 indexed citations
7.
Nguyen, Hong, Vijay Rajagopal, Magdalene K. Montgomery, et al.. (2021). EGFRvIII Promotes Cell Survival during Endoplasmic Reticulum Stress through a Reticulocalbin 1-Dependent Mechanism. Cancers. 13(6). 1198–1198. 12 indexed citations
8.
Nguyen, Hong, et al.. (2020). Reduced EGFR and increased miR-221 is associated with increased resistance to temozolomide and radiotherapy in glioblastoma. Scientific Reports. 10(1). 17768–17768. 22 indexed citations
9.
Jones, Jordan, Hong Nguyen, Katharine J. Drummond, & Andrew Morokoff. (2020). Circulating Biomarkers for Glioma: A Review. Neurosurgery. 88(3). E221–E230. 61 indexed citations
10.
González-Granero, Susana, Maria Micaela Molina‐Navarro, Jesús Pacheco‐Torres, et al.. (2016). Intraventricular injections of mesenchymal stem cells activate endogenous functional remyelination in a chronic demyelinating murine model. Cell Death and Disease. 7(5). e2223–e2223. 34 indexed citations
11.
Carter, Julia H., James A. Deddens, Bruce M. Colligan, et al.. (2016). Phosphorylation of eIF4E serine 209 is associated with tumour progression and reduced survival in malignant melanoma. British Journal of Cancer. 114(4). 444–453. 37 indexed citations
12.
Jones, Jordan, et al.. (2016). Use of tissue plasminogen activator in the treatment of shunt blockage secondary to intraventricular haemorrhage. Journal of Clinical Neuroscience. 34. 281–282. 1 indexed citations
13.
Thuy, Matthew N.T., Su Kah Goh, Lipi Shukla, et al.. (2015). A novel literature-based approach to identify genetic and molecular predictors of survival in glioblastoma multiforme: Analysis of 14,678 patients using systematic review and meta-analytical tools. Journal of Clinical Neuroscience. 22(5). 785–799. 28 indexed citations
14.
Jones, Jordan, José Luis Ivorra, Diego Pastor, et al.. (2013). Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model. Cell Death and Disease. 4(8). e779–e779. 50 indexed citations
15.
Jones, Jordan, et al.. (2013). α1‐antitrypsin and C‐reactive protein levels in tear fluid after continuous contact lens wear. Clinical and Experimental Optometry. 97(1). 66–71. 6 indexed citations
16.
Roche, Enrique, Roberto Enseñat‐Waser, Juan A. Reig, et al.. (2008). Therapeutic Potential of Stem Cells in Diabetes. Handbook of experimental pharmacology. 147–167. 4 indexed citations
17.
Jones, Jordan, Sharon S. Krag, & Michael J. Betenbaugh. (2005). Controlling -linked glycan site occupancy. Biochimica et Biophysica Acta (BBA) - General Subjects. 1726(2). 121–137. 142 indexed citations
18.
Mason, Jeffrey L., Jordan Jones, Masako Taniike, et al.. (2000). Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. Journal of Neuroscience Research. 61(3). 251–262. 181 indexed citations
19.
Jones, Jordan. (1986). Stones, lithotripters, trials, and arguments. BMJ. 292(6531). 1334.2–1334. 1 indexed citations
20.
Jones, Jordan. (1986). Technology assessment in Britain: lessons from the lithotripter. BMJ. 292(6529). 1198.2–1199. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026